These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1551347)

  • 21. Normalization of esophageal pH with high-dose proton pump inhibitor therapy does not result in regression of Barrett's esophagus.
    Sharma P; Sampliner RE; Camargo E
    Am J Gastroenterol; 1997 Apr; 92(4):582-5. PubMed ID: 9128303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranitidine therapy of Barrett's ulcer. Case report.
    Andersson R; Löwgren B
    Acta Chir Scand; 1986 Oct; 152():629-31. PubMed ID: 3811766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer.
    D'Onofrio V; Bovero E; Iaquinto G
    Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Partial regression of Barrett's esophagus by long-term therapy with high-dose omeprazole.
    Malesci A; Savarino V; Zentilin P; Belicchi M; Mela GS; Lapertosa G; Bocchia P; Ronchi G; Franceschi M
    Gastrointest Endosc; 1996 Dec; 44(6):700-5. PubMed ID: 8979061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
    Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
    Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does Barrett's esophagus regress after surgery (or proton pump inhibitors)?
    Spechler SJ
    Dig Dis; 2014; 32(1-2):156-63. PubMed ID: 24603402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Complete regression of Barrett's esophagus after drug therapy].
    Pasqualini M; Farina PG; Livorti M; Petrogalli F; Romanelli R; Schenardi C
    G Chir; 1995 Mar; 16(3):113-5. PubMed ID: 7547122
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Elevated gastric acid secretion in patients with Barrett's metaplastic epithelium.
    Mulholland MW; Reid BJ; Levine DS; Rubin CE
    Dig Dis Sci; 1989 Sep; 34(9):1329-34. PubMed ID: 2766898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of oxidative stress in experimentally induced reflux esophagitis and Barrett's esophagus: clue for the chemoprevention of esophageal carcinoma by antioxidants.
    Lee JS; Oh TY; Ahn BO; Cho H; Kim WB; Kim YB; Surh YJ; Kim HJ; Hahm KB
    Mutat Res; 2001 Sep; 480-481():189-200. PubMed ID: 11506813
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preoperative gastric acid secretion and the risk to develop Barrett's esophagus after esophagectomy for chagasic achalasia.
    da Rocha JR; Cecconello I; Ribeiro U; Baba ER; Safatle-Ribeiro AV; Iriya K; Sallum RA; Sakai P; Szachnowicz S
    J Gastrointest Surg; 2009 Nov; 13(11):1893-8; discussion 1898-9. PubMed ID: 19756883
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Idiopathic gastric acid hypersecretion: treatment implications for refractory acid/peptic disorders.
    Lewis JH
    Aliment Pharmacol Ther; 1991; 5 Suppl 1():15-24. PubMed ID: 1888834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synergism of acid and duodenogastroesophageal reflux in complicated Barrett's esophagus.
    Vaezi MF; Richter JE
    Surgery; 1995 Jun; 117(6):699-704. PubMed ID: 7778033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bile reflux in benign and malignant Barrett's esophagus: effect of medical acid suppression and nissen fundoplication.
    Stein HJ; Kauer WK; Feussner H; Siewert JR
    J Gastrointest Surg; 1998; 2(4):333-41. PubMed ID: 9841990
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of up to 3 years of high-dose lansoprazole on Barrett's esophagus.
    Sampliner RE
    Am J Gastroenterol; 1994 Oct; 89(10):1844-8. PubMed ID: 7942680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The prescribing of acid suppressants prior to the endoscopic diagnosis of Barrett's oesophagus and oesophagitis.
    Todd JA; Weston T; MacDonald TM; Johnston DA; Dillon JF
    Aliment Pharmacol Ther; 2001 Feb; 15(2):221-6. PubMed ID: 11148441
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased esophageal chemoreceptor sensitivity to acid in patients after successful reversal of Barrett's esophagus.
    Fass R; Yalam JM; Camargo L; Johnson C; Garewal HS; Sampliner RE
    Dig Dis Sci; 1997 Sep; 42(9):1853-8. PubMed ID: 9331147
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refractory duodenal ulcers (nonhealing duodenal ulcers with standard doses of antisecretory medication).
    Collen MJ; Stanczak VJ; Ciarleglio CA
    Dig Dis Sci; 1989 Feb; 34(2):233-7. PubMed ID: 2914544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specialized metaplastic columnar epithelium in Barrett's esophagus. A comparative transmission electron microscopic study.
    Levine DS; Rubin CE; Reid BJ; Haggitt RC
    Lab Invest; 1989 Mar; 60(3):418-32. PubMed ID: 2927081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The prevalence of Barrett's esophagus and erosive esophagitis in patients undergoing upper endoscopy for dyspepsia in a VA population.
    Connor MJ; Weston AP; Mayo MS; Sharma P
    Dig Dis Sci; 2004 Jun; 49(6):920-4. PubMed ID: 15309878
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Helicobacter pylori in duodenal ulcer patients with idiopathic gastric acid hypersecretion.
    Collen MJ; Strong RM
    Dig Dis Sci; 1993 Jan; 38(1):132-6. PubMed ID: 8420745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.